N1L Is an Ectromelia Virus Virulence Factor and Essential for In Vivo Spread upon Respiratory Infection
暂无分享,去创建一个
Y. Suezer | G. Sutter | U. Kalinke | K. Hanschmann | A. Volz | M. Majzoub | A. Schwantes | Melanie Kremer | Meike S. Gratz
[1] Barney S. Graham,et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo , 2010, Proceedings of the National Academy of Sciences.
[2] M. Alexander-Miller,et al. Functional Divergence among CD103+ Dendritic Cell Subpopulations following Pulmonary Poxvirus Infection , 2010, Journal of Virology.
[3] N. Letvin,et al. Efficient Generation of Mucosal and Systemic Antigen-Specific CD8+ T-Cell Responses following Pulmonary DNA Immunization , 2010, Journal of Virology.
[4] Mark P. Dodding,et al. F11-Mediated Inhibition of RhoA Signalling Enhances the Spread of Vaccinia Virus In Vitro and In Vivo in an Intranasal Mouse Model of Infection , 2009, PloS one.
[5] H. Meyer,et al. Zoonotic poxviruses , 2009, Veterinary microbiology.
[6] Daniel R. Caffrey,et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC , 2009, Nature.
[7] Geoffrey L. Smith,et al. Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection , 2008, The Journal of general virology.
[8] S. Green,et al. Robust Intrapulmonary CD8 T Cell Responses and Protection with an Attenuated N1L Deleted Vaccinia Virus , 2008, PloS one.
[9] S. Akira,et al. Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. , 2008, The Journal of clinical investigation.
[10] Hideo Negishi,et al. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules , 2008, Proceedings of the National Academy of Sciences.
[11] L. Lanier,et al. A Role for NKG2D in NK Cell–Mediated Resistance to Poxvirus Disease , 2008, PLoS pathogens.
[12] S. Jonjić,et al. Immune evasion of natural killer cells by viruses. , 2008, Current opinion in immunology.
[13] S. Akira,et al. Modified Vaccinia Virus Ankara Induces Toll-Like Receptor-Independent Type I Interferon Responses , 2007, Journal of Virology.
[14] S. Locarnini,et al. Toll‐like receptors, RIG‐I‐like RNA helicases and the antiviral innate immune response , 2007, Immunology and cell biology.
[15] K. Honda,et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.
[16] D. Stuart,et al. Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein , 2007, The Journal of general virology.
[17] J. Corbett,et al. Induction of Natural Killer Cell Responses by Ectromelia Virus Controls Infection , 2007, Journal of Virology.
[18] G. McFadden,et al. Immunopathogenesis of poxvirus infections: forecasting the impending storm , 2007, Immunology and cell biology.
[19] R. Liddington,et al. Vaccinia virus N1L protein resembles a B cell lymphoma‐2 (Bcl‐2) family protein , 2006, Protein science : a publication of the Protein Society.
[20] C. Coban,et al. Essential role of IPS-1 in innate immune responses against RNA viruses , 2006, The Journal of experimental medicine.
[21] D. Gridley,et al. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor , 2006, The journal of gene medicine.
[22] G. Karupiah,et al. Obligatory Requirement for Antibody in Recovery from a Primary Poxvirus Infection , 2006, Journal of Virology.
[23] G. Karupiah,et al. Protective Immunity against Secondary Poxvirus Infection Is Dependent on Antibody but Not on CD4 or CD8 T-Cell Function , 2006, Journal of Virology.
[24] B. Finlay,et al. Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens , 2006, Cell.
[25] R. Buller,et al. Ectromelia virus: the causative agent of mousepox. , 2005, The Journal of general virology.
[26] A. Bowie,et al. Poxvirus Protein N1L Targets the I-κB Kinase Complex, Inhibits Signaling to NF-κB by the Tumor Necrosis Factor Superfamily of Receptors, and Inhibits NF-κB and IRF3 Signaling by Toll-like Receptors* , 2004, Journal of Biological Chemistry.
[27] Fatema A. Legrand,et al. Induction of Potent Humoral and Cell-Mediated Immune Responses by Attenuated Vaccinia Virus Vectors with Deleted Serpin Genes , 2004, Journal of Virology.
[28] P. Eckburg,et al. Human monkeypox: an emerging zoonosis , 2004, The Lancet. Infectious diseases.
[29] G. McFadden,et al. Poxviruses and immune evasion. , 2003, Annual review of immunology.
[30] A. Meyers,et al. Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[31] S. Akira,et al. Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.
[32] G. McFadden,et al. Poxvirus Immunomodulatory Strategies: Current Perspectives , 2003, Journal of Virology.
[33] C. Staib,et al. Improved host range selection for recombinant modified vaccinia virus Ankara. , 2003, BioTechniques.
[34] Susana Guerra,et al. Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L , 2002, Oncogene.
[35] D. Tscharke,et al. The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. , 2002, The Journal of general virology.
[36] D A Henderson,et al. Diagnosis and management of smallpox. , 2002, The New England journal of medicine.
[37] L. Lefrançois,et al. Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue , 2001, Science.
[38] D. Smee,et al. Treatment of Lethal Vaccinia Virus Respiratory Infections in Mice with Cidofovir , 2001, Antiviral chemistry & chemotherapy.
[39] A. Alcamí,et al. Expression of Secreted Cytokine and Chemokine Inhibitors by Ectromelia Virus , 2000, Journal of Virology.
[40] A. Bowie,et al. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[41] C. Upton,et al. Ectromelia virus virulence factor p28 acts upstream of caspase-3 in response to UV light-induced apoptosis. , 2000, The Journal of general virology.
[42] L. Morrison,et al. A Poxvirus Protein That Binds to and Inactivates IL-18, and Inhibits NK Cell Response1 , 2000, The Journal of Immunology.
[43] M. Bray,et al. A mouse model of aerosol-transmitted orthopoxviral disease: morphology of experimental aerosol-transmitted orthopoxviral disease in a cowpox virus-BALB/c mouse system. , 2000, Archives of pathology & laboratory medicine.
[44] C. Upton,et al. Analysis of host response modifier ORFs of ectromelia virus, the causative agent of mousepox. , 2000, Virus research.
[45] J. Panus,et al. A third distinct tumor necrosis factor receptor of orthopoxviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[46] G. Karupiah,et al. Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection , 1996, Journal of virology.
[47] M Aguet,et al. Functional role of type I and type II interferons in antiviral defense. , 1994, Science.
[48] R. Moyer,et al. The effects of serpin gene mutations on the distinctive pathobiology of cowpox and rabbitpox virus following intranasal inoculation of Balb/c mice. , 1993, Virology.
[49] G. Karupiah,et al. Importance of interferons in recovery from mousepox , 1993, Journal of virology.
[50] K. Rajewsky,et al. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting , 1993, Cell.
[51] Susumu Tonegawa,et al. RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.
[52] P. Marrack,et al. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. , 1990, Science.
[53] B. Moss,et al. Transient dominant selection of recombinant vaccinia viruses , 1990, Journal of virology.
[54] R. Jaenisch,et al. β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells , 1990, Nature.
[55] B. Moss,et al. Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein. , 1989, Virology.
[56] S. Ho,et al. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. , 1989, Gene.
[57] B. Coupar,et al. A dominant selectable marker for the construction of recombinant poxviruses. , 1988, Gene.
[58] C. A. Phillips,et al. Vaccinia pneumonia in mice. A light and electron microscopic and viral assay study. , 1966, The American journal of pathology.
[59] F. Fenner,et al. Mouse-pox; infectious ectromelia of mice; a review. , 1949, Journal of immunology.
[60] F. Fenner. The clinical features and pathogenesis of mouse‐pox (infectious ectromelia of mice) , 1948 .
[61] J. Löwer,et al. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox. , 2009, The Journal of infectious diseases.
[62] G. Häcker,et al. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis , 2008, Cell Death and Differentiation.
[63] D. Brownstein,et al. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus , 2005, Archives of Virology.
[64] G. McFadden. Poxvirus tropism , 2005, Nature Reviews Microbiology.
[65] P. Kellam,et al. Poxvirus genomes: a phylogenetic analysis. , 2004, The Journal of general virology.
[66] G. Kotwal,et al. Growing poxviruses and determining virus titer. , 2004, Methods in molecular biology.
[67] M. Lorenzo,et al. Construction and isolation of recombinant vaccinia virus using genetic markers. , 2004, Methods in molecular biology.
[68] Antonio Alcami,et al. Viral mimicry of cytokines, chemokines and their receptors , 2003, Nature Reviews Immunology.
[69] D. Smee,et al. Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. , 2000, The Journal of infectious diseases.
[70] Geoffrey L. Smith,et al. Vaccinia virus immune evasion. , 1999, Immunology letters.
[71] E. Koonin,et al. A poxvirus protein with a RING zinc finger motif is of crucial importance for virulence. , 1994, Virology.
[72] F. Fenner. Smallpox and its eradication , 1988 .